AUS
NZ
UK
CA
USA
IND
Health
How Fulcrum Therapeutics (NASDAQ:FULC) Is Advancing in the Biopharma Industry
February 06, 2025 08:00 AM PST| By Team Kalkine MediaHighlights,Fulcrum Therapeutics has received varied ratings, reflecting diverse perspectives on its market position.,Financial institutions have set neutral and sector-based evaluations with assigned target prices.,Institutional investors continue to...
Has Spire Wealth Management Reduced Its Stake in Revvity, Inc. (NYSE:RVTY)?
February 06, 2025 07:50 AM PST| By Team Kalkine MediaHighlights,Spire Wealth Management has lowered its stake in Revvity, Inc. by 9.8% in the fourth quarter.,Institutional investors, including Janus Henderson Group PLC, State Street Corp, and Geode Capital Management LLC, have made adjustments to their...
Why Are Institutional Investors Increasing Their Stakes in CVS Health Co. (NYSE:CVS)?
February 06, 2025 07:48 AM PST| By Team Kalkine MediaHighlights,Spire Wealth Management raised its holdings in CVS Health by 27% in the fourth quarter.,A number of institutional investors increased their stakes in CVS Health during recent quarters.,CVS Health is attracting attention from significant he...
Is CVS Health Facing Institutional Portfolio Shifts?
February 06, 2025 06:53 AM PST| By Team Kalkine MediaHighlights,Institutional investors have made adjustments to their positions in CVS Health Co.,(NYSE:CVS),, with some reducing holdings significantly.,The latest filings reveal notable changes in the ownership structure among hedge funds and large fin...
Is STERIS plc (NYSE:STE) Positioned for Stability?
February 06, 2025 06:48 AM PST| By Team Kalkine MediaHighlights,STERIS plc operates within the healthcare sector, focusing on infection prevention and procedural solutions.,The company has seen fluctuations in market value, with recent changes in share prices drawing attention.,Financial data suggests...
Why Are Institutional Investors Increasing Their Holdings in Zoetis Inc. (NYSE:ZTS)?
February 06, 2025 06:41 AM PST| By Team Kalkine MediaHighlights,Institutional investors have significantly expanded their positions in Zoetis Inc.,(NYSE:ZTS),.,Several firms have recently acquired additional shares, reflecting continued interest in the company.,Zoetis remains a focal point for investme...
BD Shares Fiscal 2025 First Quarter Results and Updates Guidance for Full Year
February 06, 2025 12:43 AM PST| By Team Kalkine MediaHighlights,BD authorized the repurchase of up to 10 million shares of its common stock.,BD Medical expands U.S. manufacturing and introduces innovative needle-free blood collection.,BD increases its fiscal 2025 Adjusted Diluted EPS guidance to $14.30...
Why Are Hedge Funds Increasing Their Stake In Smith & Nephew?
February 06, 2025 12:22 AM PST| By Team Kalkine MediaWhy Are Hedge Funds Increasing Their Stake in Smith & Nephew?
Is Illumina Inc. (NASDAQ:ILMN) Gaining Institutional Confidence in the Life Sciences Sector
February 06, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Blue Trust Inc. increased its stake in Illumina by 17.4% in Q4.,Several financial firms adjusted their positions in recent quarters.,Revenue reached $1.08 billion, surpassing expectations.,Illumina Inc. operates in the life sciences sector...
How Are Share Transactions Impacting Eli Lilly’s (NYSE:LLY) Market Standing
February 06, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Financial firms revised price targets for Eli Lilly, reflecting ongoing assessments.,Large investment firms increased their holdings, while company executives made stock sales.,Market capitalization, dividend increases, and stock repurchas...
Novo Nordisk A/S Surges After Impressive Earnings Report
February 05, 2025 11:24 PM PST| By Team Kalkine MediaNovo Nordisk A/S Surges After Impressive Earnings Report
InMode Ltd. (NASDAQ:INMD) Market Performance and Institutional Activity
February 05, 2025 11:24 PM PST| By Team Kalkine MediaInMode Ltd. (NASDAQ:INMD) Market Performance and Institutional Activity
Is The Cigna Group Reinventing Health Services?
February 05, 2025 11:24 PM PST| By Team Kalkine MediaHighlights,Truist Financial revised its valuation figure for (NYSE:CI) from a higher level to a slightly lower level.,The company maintains a market cap of approximately 81.50 billion dollars.,Its Evernorth Health Services segment delivers a broad ar...
Is Regeneron Positioned to Redefine Pharma Growth?
February 05, 2025 11:24 PM PST| By Team Kalkine MediaHighlights,Regeneron Pharmaceuticals (NASDAQ:REGN) experiences revised pricing outlook by Bernstein Bank.,Quarterly report reveals higher profit per share and revenue increase.,Major institutions adjust holdings, reflecting active involvement.,Regene...
Will Regeneron Drive the Next Biopharma Breakthrough?
February 05, 2025 11:24 PM PST| By Team Kalkine MediaHighlights,Revised valuation benchmarks recorded by market observers.,A moderate consensus remains among market viewpoints.,Institutional stakes in REGN continue to be substantial.,Regeneron Pharmaceuticals,(NASDAQ:REGN),, a key player in the biophar...
Is Centene (NYSE:CNC) Leading U.S. Healthcare Transformation?
February 05, 2025 11:24 PM PST| By Team Kalkine MediaHighlights,Centene’s quarterly earnings per share surpassed consensus figures.,Revenue growth was observed in the latest quarterly report.,Institutional stakeholders increased their share in Centene.,Centene Corporation (NYSE:CNC) operates within the...
Sonoma Pharmaceuticals (SNOA) Scheduled to Announce Quarterly Earnings on Thursday
February 05, 2025 10:28 PM PST| By Team Kalkine MediaUpcoming Earnings Spotlight: Sonoma Pharmaceuticals (NASDAQ:SNOA)
What’s Behind Biohaven’s Continued Earnings Underperformance?
February 05, 2025 10:45 AM PST| By Team Kalkine MediaHighlights:,Biohaven opens with notable market capitalization.,Company reports a negative P/E ratio and underperforms earnings expectations.,Financial ratios indicate challenges in the company’s earnings trajectory.,Biohaven Ltd.,(NYSE:BHVN),is a bio...
Johnson & Johnson (NYSE:JNJ) Shows Revenue Growth Amid Market Adjustments
February 05, 2025 08:10 AM PST| By Team Kalkine MediaHighlights,Johnson & Johnson saw stock movement following updates from market participants.,Institutional entities increased their positions, showing engagement with the company.,Strong financial results, including revenue growth and steady dividend...
Vericel (NASDAQ:VCEL) Strengthening Its Position in the Biopharmaceutical Market
February 05, 2025 08:02 AM PST| By Team Kalkine MediaHighlights,Vericel expands regenerative medicine impact.,Institutional investors increase stakes in Vericel.,Innovative therapies MACI, Epicel, and NexoBrid drive growth.,Vericel Corporation is making significant strides in regenerative medicine, foc...
